Send me a link:

*Text messaging rates may apply.

 Dow Down0.42% Nasdaq Down0.05%

Vanda Pharmaceuticals, Inc. (VNDA)

-NasdaqGM
14.11 Up 0.11(0.79%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 9,143   8,783   8,709   8,319  
Cost of Revenue -   -   -   -  
Gross Profit 9,143   8,783   8,709   8,319  
Operating Expenses
Research Development7,263  6,222  8,026  5,831  
Selling General and Administrative27,893  9,851  5,711  4,879  
Non Recurring -   -   -   -  
Others565  377  377  372  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (26,578) (7,667) (5,405) (2,763)
Income from Continuing Operations
Total Other Income/Expenses Net45  44  25  30  
Earnings Before Interest And Taxes(26,533)(7,623)(5,380)(2,733)
Interest Expense -   -   -   -  
Income Before Tax(26,533)(7,623)(5,380)(2,733)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(26,533)(7,623)(5,380)(2,733)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (26,533) (7,623) (5,380) (2,733)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (26,533) (7,623) (5,380) (2,733)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.